Benzinga's Top Upgrades

Analysts at Credit Suisse upgraded Five Below FIVE from “neutral” to “outperform.” The target price for Five Below has been raised from $46 to $52. Five Below's shares closed at $42.72 on Friday. BB&T Capital upgraded Heartland Express HTLD from “hold” to “buy.” Heartland Express's shares closed at $18.79 on Friday. Analysts at William Blair upgraded ARIAD Pharmaceuticals ARIA from “market perform” to “outperform.” The target price for ARIAD Pharmaceuticals has been raised from $3 to $12. ARIAD's shares closed at $6.43 on Friday. JP Morgan upgraded United Therapeutics UTHR from “underweight” to “neutral.” The target price for United Therapeutics has been raised from $62 to $90. United Therapeutics' shares closed at $87.84 on Friday.